NR4A1 and Other metabolic disease: Moreover, the compound ethyl 2-[2,3,4-trimethoxy-6-(1-octanoyl) phenyl] acetate (TMPA) has demonstrated antagonistic effects on NR4a1 function in diabetic mice, offering promising avenues for metabolic disorder management64.